Advantages of Ang II receptor blockade over ACE inhibition with respect to suppression of sympathetic activity: heartening news for the kidney?
Rump
L C
LC
Medizinische Universitätsklinik Freiburg, Innere Medizin IV, Germany.
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D006321:Heart / Q000294:innervation; D006801:Humans; D007668:Kidney / Q000294:innervation; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D013564:Sympathetic Nervous System / Q000187:drug effects*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002395:Catecholamines; D001920:Bradykinin